Home | NHS Research Scotland - Awarded Pfizer global ......Supporting commercial research in NHS...

www.nrs.org.uk @NHSResearchScot communications@nrs.org.uk

Supporting commercial research in NHS Scotland

Scotland is the only entire country to be considered a Pfizer INSPIRE Site providing:

• Access to a population of c.5million

• Some of the best health data in the world

• Collaborative approach to research

• High burden of disease

•Efficientsupportforstudystartup

INSPIRE sitesarepartofPfizer’sinternationalnetwork of preferred locations for clinical research, helping to bring innovative medicines to patients in the UK and around the world. Therearecurrentlyover90PfizerINSPIRE sites across the world.

INSPIRE sites areidentifiedashighlyproductiveandeffectiveinconductingclinicaltrials; and meet strict criteria including running trials to the highest standards within set timelines; ensuring dedicated, high-quality staffandresources;andexpertiseinkeydiseaseareastargetedbyPfizer’sR&Dpipeline.

“Our unique relationship with NHS Scotland enables us to provide country intelligence to our global Physicians and feasibility teams, thus increasing the awareness of the research infrastructure available in Scotland . The collaborative nature of our relationship has increased process improvements towards enhanced study milestones, enabling us to work together to achieve our joint goal of best in class” Nikki Dewick, Director of Clinical Site Management, UK and Ireland

Awarded Pfizer global INSPIRE status in 2013, making Scotland a location of choice for Pfizer studies

2nd highest recruiting site in UK for Huntington’s Disease

and recruited the first patient in UK and Europe

First patient in UK for Oncology (Lung and Endometrial) studies

First patient in UK for Hypercholesterolemia study

First patient in the UK for an Oncology Pain study

First patient in UK and highest UK recruiting site for a

Crohn’s Disease study

NHS Research Scotland works alongside industry to maintain Scotland’s position as a world leader in research

Further information To discuss placing a trial in Scotland contact Steven Burke, Industry Liaison Manager

steven.burke@nrs.org.uk / +44 141 951 5508 or visit www.nrs.org.uk/industry

NHS Research Scotland (NRS) is a partnership of Scottish NHS Boards and the Chief Scientist Office of Scottish Government. Registered Number: GB 236303. Registered address: The Golden Jubilee National Hospital, Fourth Floor East, Agamemnon St, Clydebank, G81 4DY

Published by NHS Research Scotland. All rights reserved. Material contained in this publication may not be reproduced in whole or part without prior per-mission of NHS Research Scotland (or other copyright owners). While every effort is made to ensure that the information given here is accurate, no legal responsibility is accepted for any errors, omissions or misleading statements.

www.nrs.org.uk @NHSResearchScot communications@nrs.org.uk

“Scotland’s status as a Pfizer INSPIRE site boosts Scotland’s reputation as a global centre of excellence for research and creates the opportunity to increase the number of novel products and innovative medical advances which patients in Scotland can access”

Dr Steven Burke, Industry Liaison Manager, NHS Research Scotland

INSPIRE Partnership ProgrammeCollaboration with NHS Research Scotland is key to support delivery of Pfizer trials in Scotland• Provides access to a large number of Investigators across

ALL Therapeutic Areas (TAs) in which Pfizer is conducting clinical research

• Clinical Investigators in Scotland are prioritised to be approached for interest in Pfizer clinical trials

• Pfizer portfolio shared 12-18 months ahead of predicted study start-up

• Pfizer Project Teams connected to Investigator Sites in Scotland

• Opportunity to increase the number of novel products, which patients in Scotland can have access to

• Dedicated point of contacts at Pfizer and NHS Research Scotland support efficiency and strong relationships

• Master Contract Template agreed for Pfizer studies

• Umbrella Confidentiality Agreement in place with Health Boards

• “Go To” sites for piloting of Pfizer new clinical trial processes

TheINSPIREpartnershipputsthe

NHSatthecentreofallstagesof

research, from identifying priorities

and areas for study, carrying out

studies, engaging patients in

researchandputtingthefindings

into evidence based practice.